<<<Sunday
Monday, June 25, 2007

7:00 AM-8:00 AM BDRB EDITORIAL BOARD MEETING-Conference Center C (Conference Level)
   
8:00 AM-5:00 PM REGISTRATION-17th Floor Alcove
   
8:00 AM–8:15 AM
PRESIDENT’S WELCOME-Grand Ballroom (17th Floor)
Elaine M. Faustman
 
8:15 AM–9:10 AM

JOSEF WARKANY LECTURE-Grand Ballroom (17th Floor)

Fetal Alcohol Spectrum Disorders from Teratology to Public Health
Speaker: Ann P. Streissguth, University of Washington School Of Medicine

 

9:10 AM–9:40 AM JAMES G. WILSON PUBLICATION AWARD-Grand Ballroom (17th Floor)
   
9:45 AM–11:30 AM STUDENT / POSTDOCTORAL FELLOW PLATFORM SESSION-Grand Ballroom (17th Floor)
Organized by the Student Affairs Committee, Gary M. Shaw, Chairperson
9:45 AM-10:00 AM 5 Role of Retinoic Acid Receptor(y) in Regulating the Expression of Genes Important in Chondrogenesis and Cell Death in the Murine Limb
    Galdones E, Hales BF. Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
10:00 AM-10:15 AM 6 Human Embryo Atlas Constructed by Magnetic Resonance (MR) Imaging and Episcopic Fluorescence Image Capture (EFIC) from the Kyoto Collection of Human Embryos
    Yamada S1,2, Anderson SA1, Lockett E3, Uwabe C2, Shiota K2, Lo CW1. 1National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States, 2Congenital Anomaly Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3National Museum of Health & Medicine, Human Developmental Anatomy Center, Washington, DC, United States.
10:15 AM-10:30AM 7 Low Nitric Oxide Availability is a Key Factor Underlying Copper Deficiency Teratogenicity
    Yang SJ, Lanoue L, Keen CL, Rucker RB, Uriu-Adams JY. University of California, Davis, Davis, CA, United States.
10:30 AM-10:45 AM   Break
10:45 AM-11:00 AM 8 Release of p53 from Mitochondrial Matrix to the Nucleus During Cellular Stress: Influence of PK11195
    Green ML, Singh AV, Knudsen TB. University of Louisville, Louisville, KY, United States.
11:00 AM-11:15 AM 9 Does the Risk of Spontaneous Abortion Differ by Prenatal Exposure to Wine, Spirits or Beer?
    Ammon LN1,2, Kaskutas LA1,2, Li DK3. 1University of California Berkeley, School of Public Health, Deparment of Epidemiology, Berkeley, CA, United States, 2Alcohol Research Group, Emerville, CA, United States, 3Kaiser Permanente, Division of Research, Oakland, CA, United States.
11:15 AM-11:30 AM 10 Changes in Placental Th1 Cytokines and Apoptosis After Infection of Guinea Pigs With Listeria Monocytogenes
    Irvin EA1,2, Williams D1, Jensen A1,3, Richardson AN1, Smith MA1,2. 1Department of Environmental Health Science, Athens, GA, United States, 2Center for Food Safety, Griffin, GA, United States, 3Danish Institute for Fisheries Research, Denmark.
   
11:30 AM-12:30 PM LUNCH ON OWN
   
11:30 AM-1:00 PM STUDENT AFFAIRS COMMITTEE MEETING-Allegheny (17th Floor)
   
11:30 AM–1:00 PM PAST PRESIDENT’S LUNCH (By Invitation Only)
   
1:00 PM–2:00 PM ROBERT L. BRENT LECTURE
Sponsored by Charles River Laboratories, Inc.
Alcohol and Pregnancy: What Have We Learned in 30 Years?
Speaker: Kenneth Lyons Jones, University of California, San Diego
   
2:00 PM–5:30 PM TS/NBTS/OTIS JOINT SYMPOSIUM-Urban (17th Floor)

Fetal Alcohol Spectrum Disorders (FAS/FASD)
Chairpersons: Dee L. Quinn, University of Arizona and Judith A. Wubah, James Madison University

2:00 PM-2:35 PM S5 Measuring Worldwide Incidence of FASD
    Speaker: Christina D. Chambers, University of California, San Diego
2:35 PM-3:10 PM S6 Effects of Prenatal Alcohol Exposure on Brain and Behavior
    Speaker: Edward P. Riley, San Diego State University
3:10 PM-3:45 PM S7 Functional Imaging Studies of Cognitive Outcomes in FASD
    Speaker: Jennifer A. Willford, University of Pittsburgh
3:45 PM-4:05 PM   Break
4:05 PM-4:40 PM S8 Outcomes of Pregnancies Exposed to Low to Moderate Levels of Alcohol
    Speaker: Nancy L. Day, University of Pittsburgh
4:40 PM-5:15 PM S9 Imaging and Mechanism Studies in an FASD Mouse Model
    Speaker: Kathleen Sulik, University of North Carolina at Chapel Hill
5:15 PM-5:30 PM   Discussion
   
2:00 PM–5:30 PM PLATFORM SESSION 1-Grand Ballroom (17th Floor)
Basic and Clinical Teratology

Chairpersons: Barbara Hales, McGill University and Michael F. O'Hara, Novartis Pharmaceuticals

2:00 PM-2:15 PM 11 Developmental Toxicity Signals Observed for 17á-Hydroxyprogesterone Caproate in High Risk Pregnancies in the Non-Clinical Literature for Developmental Toxicity of Progestins
    Christian MS1, Brent RL2, Calda P3. 1Argus International,Inc., Horsham, PA, United States, 2Jefferson Medical College and duPont Hospital for Children, Wilmington, DE, United States, 3Charles University, First Medical School, Department of Obstetrics and Gynecology, Prague, Czech Republic.
2:15 PM-2:30 PM 12 Risk of Major Malformations Among Infants Exposed to Carbamazepine During Pregnancy
    Hernandez-Diaz S2, Smith CR1, Wyszynski DF3, Holmes LB1. 1MassGeneral Hospital for Children, Boston, MA, United States, 2Harvard School of Public Health, Boston, MA, United States, 3Boston University School of Medicine, Boston, MA, United States.
2:30 PM-2:45 PM 13 Paroxetine Use in Pregnancy: Is There an Association With Congenital Cardiovascular Defects?
    Einarson A1, Pistelli A2, Desantis M3, Malm H4, Paulus WE5, Panchaud A6, Kennedy D7, Einarson TR1,8, Koren G1. 1The Motherisk Program, The Hospital for Sick Children, Toronto, ON, Canada, 2Servizio di Tossicologia Perinatale, Firenze, Italy, 3Telefona Rosa, Rome, Italy, 4Teratology Information Service, Helsinki, Finland, 5Teratology Information Service, Ravensburg, Germany, 6Swiss Teratogen Information Service, Lausanne, Switzerland, 7The Mothersafe Program, Sydney, Australia, 8Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, 9The Motherisk Program, Toronto, ON, Canada.
2:45 PM-3:00 PM 14 Duration of Antidepressant Use During Pregnancy and Risk of Major Congenital Malformations
    Ramos E1,2, St-Andre M1,2, Rey E1,2, Oraichi D2, Berard A1,2. 1University of Montreal, Montreal, QC, Canada, 2CHU Sainte-Justine, Montreal, QC, Canada.
3:00 PM-3:15 PM 15 Neurodevelopment After Prenatal Exposure to Antidepressant Medication
    Pedersen LH1,2, Henriksen TB2, Olsen J3. 1The Danish Epidemiology Science Center, Institute of Public Health, University of Aarhus, Aarhus, Denmark, 2Perinatal Epidemiology Research Unit, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark, 3UCLA School of Public Health, Department of Epidemiology, Los Angeles, CA, United States.
3:15 PM-3:30 PM 16 Nutrient Intakes in Women and Congenital Diaphragmatic Hernia in Their Offspring
    Yang W1, Shaw GM1, Carmichael SL1, Rasmussen SA2, Waller DK3, Pober BR4,5, Anderka M6. 1California Birth Defect Monitoring Program, Berkeley, CA, United States, 2Centers for Disease Control and Prevention, Atlanta, GA, United States, 3School of Public Health, University of Texas Health Science Center, Houston, TX, United States, 4MassGeneral Hospital for Children, Boston, MA, United States, 5Children's Hospital, Boston, MA, United States, 6Bureau of Family and Community Health, Massachusetts Department of Public Health, Boston, MA, United States.
3:30 PM-3:45 PM 17 Maternal Folate, Vitamin B-6, and Homocysteine Levels and Risk of Oral Clefts in Utah
    Munger RG1, Johnson KE2, Feldkamp M3, Phister R1, Cutler DR1, Botto L4, Carey J4, Tamura T2. 1Utah State University, Logan, UT, United States, 2University of Alabama at Birmingham, Birmingham, AL, United States, 3Utah Department of Health, Salt Lake City, UT, United States, 4University of Utah, Salt Lake City, UT, United States.
3:45 PM-4:00 PM   Break
4:00 PM-4:15 PM 18 Ventilatory Response to Hypercapnia in Rats Exposed to Fluoxetine In Utero
    Boucher N1,2, Saad N1,2, Joseph V2, Beaulac-Baillargeon L1,2. 1Laval University, Faculty of Pharmacy, Quebec, QC, Canada, 2CHUQ Research Center, Perinatalogy Unit, Quebec, QC, Canada.
4:15 PM-4:30 PM 19 Skeletal Anomalies in Novel Mutant Mouse Models With Congenital Cardiac Anomalies
    Gibbs BC1, Schimel D2, YuQ, Lo CW1. 1Laboratory of Developmental Biology, NHLBI/NIH, and 2Mouse Imaging Facility, NINDS/NIH Bethesda, MD, USA
4:30 PM-4:45 PM 20 Dihydroartemisinin (DHA) Treatment Causes Decreased Proliferation and Apoptosis in Rat Embryonic Erythroblasts in Whole Embryo Culture
    Posobiec LM, Bushdid PB, Laffan SB, Clark RC, White TE. Safety Assessment, GlaxoSmithKline, King of Prussia, PA, United States.
4:45 PM-5:00 PM 21 Autoradiography Reveals Specific Labeling of Embryonic and Fetal Red Blood Cells by the Anti-Malarial, Artesunate
    White TE1, Lordi AW2, Bushdid PB1, Cox EM1, Floyd LE1, Fishman CE1, Solon EG2, Clark RL1. 1GlaxoSmithKline, King of Prussia, PA, United States, 2Quest Pharmaceutical Services, LLC, Newark, DE, United States.
5:00 PM-5:15 PM 22 Craniosynostosis and Maternal Smoking
    Carmichael SL1, Ma C1, Rasmussen SA2, Honein MA2, Lammer EJ3, Shaw GM1. 1March of Dimes, California Birth Defects Monitoring Program, Berkeley, CA, United States, 2National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States, 3Children's Hospital Research Institute, Oakland, CA, United States.
5:15 PM-5:30 PM 23 Pregnancy Outcome Following Early Gestational Exposure to Leflunomide
    Chambers CD, Jones KL, Johnson DL, OTIS Collaborative Research Group. University of California San Diego, La Jolla, CA, United States.

   
5:30 PM–7:30 PM

TS/NBTS/OTIS JOINT POSTER SESSION AND EXHIBITS OPEN-William Penn Ballroom (WP Level)
Epidemiology–Clinical Teratology
Sponsored by Covance, Endo Pharmaceuticals, and Noblis, Inc.

Society for Birth Defects Research and Prevention Posters: P1-P19
NBTS Posters: NBTS20-NBTS29
OTIS Posters: OTIS P1-OTIS P5

   
7:30 PM–10:30 PM STUDENT CAREER EVENT-Bob & Dolores Hope Room (Mezzanine Level)
Sponsored by MTA / MARTA

 

rev. 24-April, 2007

© Copyright Society for Birth Defects Research and Prevention 1998-2006, 2007.
Please read our disclaimer.